Publication | Open Access
Screening of wild deer populations for exposure to SARS‐CoV‐2 in the United Kingdom, 2020–2021
27
Citations
17
References
2022
Year
Virus EpidemiologyUk Deer SeraUnited KingdomHuman-wildlife RelationshipCovid-19Uk DeerSurrogate NeutralizationEmerging Infectious DiseaseCovid-19 PandemicVirologyEpidemiologyVaccinationWild Deer PopulationsEmerging Infectious DiseasesZoonotic DiseaseEmergent VirusWildlife ManagementDisease TransmissionMedicineAnimal Virus
Following findings in Northern America of SARS-CoV-2 infections in white-tailed deer, there is concern of similar infections in European deer and their potential as reservoirs of SARS-CoV-2 including opportunities for the emergence of new variants. UK deer sera were collected in 2020-2021 from 6 species and a hybrid with 1748 tested using anti-spike and anti-nucleocapsid serology assays. No samples were positive on both assays nor by surrogate neutralization testing. There is no evidence that spill-over infections of SARS-CoV-2 occurred from the human population to UK deer or that SARS-CoV-2 has been circulating in UK deer (over the study period). Although it cannot be ruled out, study results indicate that spill-over infections followed by circulation of SARS-CoV-2 to the most common European deer species is small.
| Year | Citations | |
|---|---|---|
Page 1
Page 1